Study Summary
This trial is to see if vein mapping before facial injection procedures impacts patient outcomes and satisfaction.
Treatment Effectiveness
Effectiveness Progress
Study Objectives
1 Primary · 1 Secondary · Reporting Duration: Approximately 7-10 days following the procedure
Day 10
Patient satisfaction
Rate of Bruising/Hematoma
Trial Safety
Safety Progress
Trial Design
2 Treatment Groups
Control Goup
1 of 2
Intervention Group
1 of 2
Active Control
Experimental Treatment
60 Total Participants · 2 Treatment Groups
Primary Treatment: Accuvein® Veinfinder · No Placebo Group · N/A
Intervention Group
Device
Experimental Group · 1 Intervention: Accuvein® Veinfinder · Intervention Types: DeviceControl GoupNoIntervention Group · 1 Intervention: Control Goup · Intervention Types:
Trial Logistics
Trial Timeline
Screening: ~3 weeks
Treatment: Varies
Reporting: approximately 7-10 days following the procedure
Who is running the clinical trial?
Mayo ClinicLead Sponsor
2,919 Previous Clinical Trials
3,516,920 Total Patients Enrolled
William Casey III, MDPrincipal InvestigatorMayo Clinic
Eligibility Criteria
Age 18+ · All Participants · 1 Total Inclusion Criteria
Mark “Yes” if the following statements are true for you:Who else is applying?
What state do they live in?
| California | 100.0% |
How old are they?
| 18 - 65 | 100.0% |
What portion of applicants met pre-screening criteria?
| Did not meet criteria | 100.0% |
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top
Conditions
Cancer Related
Treatments